Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients — Dogliotti et al. — Heart

In this network meta-analysis, novel oral anticoagulants were the most promising treatments to reduce stroke, stroke or systemic embolism, and all-cause mortality in patients with AF.

via Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients — Dogliotti et al. — Heart.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s